Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Allergy Retrieve available abstracts of 222 articles: HTML format

Single Articles

April 2024
1. AGACHE I, Annesi-Maesano I, Cecchi L, Biagioni B, et al
   EAACI guidelines on environmental science for allergy and asthma: The impact of short-term exposure to outdoor air pollutants on asthma-related outcomes and recommendations for mitigation measures.
   Allergy. 2024 Apr 2. doi: 10.1111/all.16103.
   PubMed     Abstract available
   
   
   March 2024
2. JUTEL M, Klimek L, Richter H, Bruggenjurgen B, et al
   House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
   Allergy. 2024 Mar 2. doi: 10.1111/all.16052.
   PubMed     Abstract available
   
   
   
3. OKUNISHI K, Kochi Y, Zhao M, Wang H, et al
   Munc13-4 regulates asthma and obesity in mice by controlling functions of CD11c(+) antigen-presenting cells.
   Allergy. 2024 Mar 1. doi: 10.1111/all.16087.
   PubMed    
   
   
   February 2024
4. CARUSO C, Ciasca G, Baglivo I, Di Santo R, et al
   Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
   Allergy. 2024 Feb 29. doi: 10.1111/all.16082.
   PubMed     Abstract available
   
   
   
5. NADIF R, Henny J, Tsiavia T, Ribet C, et al
   Blood basophils and asthma among participants from CONSTANCES, the French population-based cohort.
   Allergy. 2024 Feb 29. doi: 10.1111/all.16093.
   PubMed    
   
   
   
6. CHEN X, He YQ
   Correspondence to "intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes".
   Allergy. 2024 Feb 25. doi: 10.1111/all.16075.
   PubMed    
   
   
   
7. OKADA N, Oguma T, Asano K
   Reply to Correspondence to "Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-factor analysis".
   Allergy. 2024 Feb 21. doi: 10.1111/all.16074.
   PubMed    
   
   
   
8. DEL DUCA E, Dahabreh D, Kim M, Bar J, et al
   Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities.
   Allergy. 2024 Feb 20. doi: 10.1111/all.16060.
   PubMed     Abstract available
   
   
   
9. NI D, Senior AM, Raubenheimer D, Simpson SJ, et al
   Global associations of macronutrient supply and asthma disease burden.
   Allergy. 2024 Feb 19. doi: 10.1111/all.16067.
   PubMed    
   
   
   
10. DEVILLIERS MA, Brisebarre A, Petit LMG, Polette M, et al
    Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma.
    Allergy. 2024 Feb 19. doi: 10.1111/all.16063.
    PubMed    
    
    
    
11. AGACHE I, Canelo-Aybar C, Annesi-Maesano I, Cecchi L, et al
    The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
    Allergy. 2024 Feb 17. doi: 10.1111/all.16051.
    PubMed     Abstract available
    
    
    
12. MORTZ CG, Parke L, Rasmussen HM, Kjaer HF, et al
    A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy.
    Allergy. 2024 Feb 17. doi: 10.1111/all.16046.
    PubMed     Abstract available
    
    
    
13. SANTOS AF
    Is there a direct link between skin barrier dysfunction and asthma?
    Allergy. 2024 Feb 13. doi: 10.1111/all.16055.
    PubMed    
    
    
    
14. FARHAN AJ, Kothalawala DM, Kurukulaaratchy RJ, Granell R, et al
    Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores.
    Allergy. 2024 Feb 13. doi: 10.1111/all.16059.
    PubMed    
    
    
    
15. ODLING M, Lagercrantz B, Goksor E, Sandelowsky H, et al
    Transitional care of adolescents and young adults with asthma and allergy-The healthcare professional perspective.
    Allergy. 2024 Feb 9. doi: 10.1111/all.16047.
    PubMed    
    
    
    
16. RICK EM, Woolnough K, Richardson M, Monteiro W, et al
    Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.
    Allergy. 2024 Feb 9. doi: 10.1111/all.16032.
    PubMed     Abstract available
    
    
    
17. AGACHE I, Canelo-Aybar C, Annesi-Maesano I, Cecchi L, et al
    The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
    Allergy. 2024 Feb 4. doi: 10.1111/all.16041.
    PubMed     Abstract available
    
    
    
18. OKUBO H, Nakayama SF, Ohya Y
    Periconceptional maternal diet quality and offspring wheeze trajectories: Japan Environment and Children's Study.
    Allergy. 2024;79:393-403.
    PubMed     Abstract available
    
    
    
19. PAPADOPOULOS NG, Akdis CA, Akdis M, Damialis A, et al
    Addressing adverse synergies between chemical and biological pollutants at schools-The 'SynAir-G' hypothesis.
    Allergy. 2024;79:294-301.
    PubMed     Abstract available
    
    
    January 2024
20. SMILNAK GJ, Lee Y, Chattopadhyay A, Wyss AB, et al
    Plasma protein signatures of adult asthma.
    Allergy. 2024 Jan 23. doi: 10.1111/all.16000.
    PubMed     Abstract available
    
    
    
21. FARDIG M, Hoyer A, Almqvist C, Bains KES, et al
    Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.
    Allergy. 2024 Jan 18. doi: 10.1111/all.16024.
    PubMed     Abstract available
    
    
    
22. CHANG KY, Lu CT, Yii CY, Yong SB, et al
    Correspondence to "Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis".
    Allergy. 2024 Jan 16. doi: 10.1111/all.16016.
    PubMed    
    
    
    
23. WON J, Jo A, Kim S, Shin H, et al
    Distinct dampening of IL-33 following inhalation of interferon-lambda in the respiratory epithelium of in vivo asthma.
    Allergy. 2024 Jan 11. doi: 10.1111/all.16010.
    PubMed    
    
    
    
24. HEKKING PP, Zhang K, Garrido CPV, Lopez-Rodriguez R, et al
    Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma.
    Allergy. 2024 Jan 10. doi: 10.1111/all.16011.
    PubMed    
    
    
    
25. KIMURA Y, Suzukawa M, Jo T, Hashimoto Y, et al
    Epidemiology of severe childhood asthma in Japan: A nationwide descriptive study.
    Allergy. 2024 Jan 7. doi: 10.1111/all.16008.
    PubMed    
    
    
    
26. PEREZ DE LLANO L, Urrutia I, G Cosio B, Gullon-Blanco JA, et al
    Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients.
    Allergy. 2024 Jan 5. doi: 10.1111/all.15999.
    PubMed    
    
    
    
27. VOSKAMP AL, de Jong NW, Jochems SP, Ozir-Fazalalikhan A, et al
    Early expansion of allergen-responsive LAP(+) B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy.
    Allergy. 2024 Jan 3. doi: 10.1111/all.15973.
    PubMed    
    
    
    
28. NOPSOPON T, Barrett NA, Phipatanakul W, Laidlaw TM, et al
    Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab.
    Allergy. 2024 Jan 2. doi: 10.1111/all.16002.
    PubMed     Abstract available
    
    
    December 2023
29. CAMINATI M, Buhl R, Corren J, Hanania NA, et al
    Tezepelumab in patients with allergic and eosinophilic asthma.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15986.
    PubMed     Abstract available
    
    
    
30. HAMELMANN E, Hammerby E, Scharling KS, Pedersen M, et al
    Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
    Allergy. 2023 Dec 26. doi: 10.1111/all.15985.
    PubMed     Abstract available
    
    
    
31. LEE E, Rhee EH, Yu J, Kim K, et al
    Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID-19 pandemic.
    Allergy. 2023 Dec 23. doi: 10.1111/all.15992.
    PubMed    
    
    
    
32. SCHWARTZ BS, Hirsch AG, Bandeen-Roche K, Kato A, et al
    Reply to "correspondence to 'association between chronic rhinosinusitis and new onset asthma implications for prevention'".
    Allergy. 2023 Dec 14. doi: 10.1111/all.15984.
    PubMed    
    
    
    
33. CHENG I, Yii CY, Shih LC, Wang JY, et al
    Correspondence to 'association between chronic rhinosinusitis and new onset asthma implications for prevention'.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15965.
    PubMed    
    
    
    
34. SMOLINSKA S, Popescu FD, Izquierdo E, Antolin-Amerigo D, et al
    Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15964.
    PubMed     Abstract available
    
    
    
35. NUNOMURA S, Ito R, Nanri Y, Ohno Y, et al
    Novel mechanisms by which benralizumab suppresses IgE expression in human B cells in humanized mice.
    Allergy. 2023;78:3271-3273.
    PubMed    
    
    
    
36. SULLIVAN MO, Curtin M, Flynn R, Cronin C, et al
    Telehealth interventions for transition to self-management in adolescents with allergic conditions: A systematic review.
    Allergy. 2023 Dec 1. doi: 10.1111/all.15963.
    PubMed     Abstract available
    
    
    November 2023
37. PHAM DD, Hong C, Lee JH, Kwon HS, et al
    Longitudinal asthma phenotypes by multi-trajectory analysis.
    Allergy. 2023 Nov 29. doi: 10.1111/all.15958.
    PubMed    
    
    
    
38. CHEN Y, Checa A, Zhang P, Huang M, et al
    Sphingolipid classes and the interrelationship with pediatric asthma and asthma risk factors.
    Allergy. 2023 Nov 28. doi: 10.1111/all.15942.
    PubMed     Abstract available
    
    
    
39. SCHMID-GRENDELMEIER P, Gooderham MJ, Hartmann K, Konstantinou GN, et al
    Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.
    Allergy. 2023 Nov 21. doi: 10.1111/all.15952.
    PubMed     Abstract available
    
    
    
40. LINDQVIST M, Leth-Moller KB, Linneberg A, Kull I, et al
    Natural course of pollen-induced allergic rhinitis from childhood to adulthood: A 20-year follow up.
    Allergy. 2023 Nov 2. doi: 10.1111/all.15927.
    PubMed     Abstract available
    
    
    October 2023
41. CAMINATI M, Fassio A, Alberici F, Baldini C, et al
    Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.
    Allergy. 2023 Oct 31. doi: 10.1111/all.15934.
    PubMed    
    
    
    
42. SAARIMAKI L, Kivisto J, Palmu S, Protudjer JLP, et al
    Trends in severe allergic reactions of adults in Finland between 1999 and 2020: A national population study.
    Allergy. 2023 Oct 30. doi: 10.1111/all.15929.
    PubMed    
    
    
    
43. GAUTAM S, Chu JH, Cohen AJ, Kaur R, et al
    Sputum alarmins delineate distinct T2 cytokine pathways and unique subtypes of patients with asthma.
    Allergy. 2023 Oct 24. doi: 10.1111/all.15915.
    PubMed    
    
    
    
44. SVERRILD A, Cerps S, Nieto-Fontarigo JJ, Ramu S, et al
    Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma.
    Allergy. 2023 Oct 17. doi: 10.1111/all.15918.
    PubMed     Abstract available
    
    
    
45. KIM JH, Lee E, Ha EK, Shin J, et al
    Cascade of atopic dermatitis comorbidities in children after birth for 15 years.
    Allergy. 2023 Oct 16. doi: 10.1111/all.15917.
    PubMed     Abstract available
    
    
    
46. VULTAGGIO A, Accinno M, Vivarelli E, Mecheri V, et al
    Blood CD62L(low) inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab.
    Allergy. 2023 Oct 4. doi: 10.1111/all.15909.
    PubMed     Abstract available
    
    
    
47. VAN DER LANS RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, et al
    Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.
    Allergy. 2023;78:2684-2697.
    PubMed     Abstract available
    
    
    September 2023
48. SVENNINGSEN S, Kjarsgaard M, Zhang K, Serajeddini H, et al
    Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma.
    Allergy. 2023 Sep 26. doi: 10.1111/all.15901.
    PubMed    
    
    
    
49. JIA M, Fu H, Jiang X, Wang L, et al
    DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma.
    Allergy. 2023 Sep 8. doi: 10.1111/all.15882.
    PubMed     Abstract available
    
    
    
50. LU C, Wang F, Qiao Z, Deng M, et al
    Extreme temperatures exacerbated oxidative stress and airway inflammation in a mouse model of allergic asthma.
    Allergy. 2023 Sep 7. doi: 10.1111/all.15883.
    PubMed    
    
    
    
51. FARHAN AJ, Kothalawala DM, Kurukulaaratchy RJ, Granell R, et al
    Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores.
    Allergy. 2023 Sep 3. doi: 10.1111/all.15876.
    PubMed     Abstract available
    
    
    August 2023
52. GUILLEMINAULT L, Villeneuve T, Didier A, Reber LL, et al
    Maintained effect of endoscopic sinus surgery in asthma responders to drugs targeting the IL5 pathway with persistent nasal polyposis.
    Allergy. 2023 Aug 31. doi: 10.1111/all.15874.
    PubMed    
    
    
    
53. THOMAS D, McDonald VM, Stevens S, Harvey ES, et al
    Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
    Allergy. 2023 Aug 25. doi: 10.1111/all.15867.
    PubMed     Abstract available
    
    
    
54. ALVARADO-VAZQUEZ PA, Mendez-Enriquez E, Salomonsson M, Waern I, et al
    Circulating mast cell progenitors increase during natural birch pollen exposure in allergic asthma patients.
    Allergy. 2023 Aug 24. doi: 10.1111/all.15860.
    PubMed     Abstract available
    
    
    July 2023
55. ADAM T, Divaret-Chauveau A, Roduit C, Adel-Patient K, et al
    Complementary feeding practices are related to the risk of food allergy in the ELFE cohort.
    Allergy. 2023 Jul 26. doi: 10.1111/all.15828.
    PubMed     Abstract available
    
    
    
56. ALHAMDAN F, Greulich T, Daviaud C, Marsh LM, et al
    Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma.
    Allergy. 2023 Jul 24. doi: 10.1111/all.15824.
    PubMed     Abstract available
    
    
    
57. KORTEKAAS KROHN I, Badloe FMS, Herrmann N, Maintz L, et al
    Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march.
    Allergy. 2023 Jul 24. doi: 10.1111/all.15822.
    PubMed     Abstract available
    
    
    
58. YANG X, Zhao J, Sima Y, Zhao Y, et al
    The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID-19): A national survey in China.
    Allergy. 2023 Jul 21. doi: 10.1111/all.15823.
    PubMed    
    
    
    
59. OKADA N, Yamamoto Y, Oguma T, Tanaka J, et al
    Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.
    Allergy. 2023 Jul 17. doi: 10.1111/all.15820.
    PubMed     Abstract available
    
    
    
60. CHEN T, Shi S, Li X, Zhou L, et al
    Improved ambient air quality is associated with decreased prevalence of childhood asthma and infancy shortly after weaning is a sensitive exposure window.
    Allergy. 2023 Jul 17. doi: 10.1111/all.15815.
    PubMed     Abstract available
    
    
    
61. KAPPEN J, Diamant Z, Agache I, Bonini M, et al
    Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper.
    Allergy. 2023 Jul 14. doi: 10.1111/all.15817.
    PubMed     Abstract available
    
    
    
62. PAVORD ID, Bourdin A, Papi A, Domingo C, et al
    Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose.
    Allergy. 2023 Jul 11. doi: 10.1111/all.15792.
    PubMed     Abstract available
    
    
    
63. SHIN YH, Hwang J, Kwon R, Lee SW, et al
    Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
    Allergy. 2023 Jul 11. doi: 10.1111/all.15807.
    PubMed     Abstract available
    
    
    
64. MUBANGA M, Brew BH, Karim H, Curman P, et al
    Maternal body mass index in pregnancy and offspring asthma and food allergy.
    Allergy. 2023 Jul 5. doi: 10.1111/all.15803.
    PubMed    
    
    
    
65. THARAKAN A, Kumar A, Allegood J, Cowart LA, et al
    D-2-hydroxyglutarate suppresses allergic sensitization in a murine model of experimental asthma.
    Allergy. 2023 Jul 5. doi: 10.1111/all.15809.
    PubMed    
    
    
    June 2023
66. KIM SH, Kim SP, Song JI, Kim Z, et al
    Causal relationship between asthma outpatient visits and air pollution with instrumental variable approach.
    Allergy. 2023 Jun 26. doi: 10.1111/all.15791.
    PubMed    
    
    
    
67. SCHLEICH F, Maury E, Bachert C, Hanon S, et al
    Epidemiology of sensitization to perennial aeroallergens in adults with severe asthma in Belgium. The BEIgE study.
    Allergy. 2023 Jun 21. doi: 10.1111/all.15785.
    PubMed    
    
    
    
68. PRICE OJ, Del Giacco S, Gawlik R, Janson C, et al
    Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspective.
    Allergy. 2023 Jun 20. doi: 10.1111/all.15789.
    PubMed    
    
    
    
69. VERSI A, Ivan FX, Abdel-Aziz MI, Bates S, et al
    Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation.
    Allergy. 2023 Jun 7. doi: 10.1111/all.15776.
    PubMed     Abstract available
    
    
    May 2023
70. SOHN KH, Choi S, Jung JW, Choi JH, et al
    Different inflammatory features of asthma according to gut microbiome enterotype.
    Allergy. 2023 May 18. doi: 10.1111/all.15768.
    PubMed    
    
    
    
71. SCHWARTZ BS, Pollak JS, Bandeen-Roche K, Hirsch AG, et al
    Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year.
    Allergy. 2023 May 17. doi: 10.1111/all.15771.
    PubMed     Abstract available
    
    
    
72. XU E, Cao G, Yang Z, Zhang Y, et al
    Adventitial stromal cells and myofibroblasts recruit pro- and anti- inflammatory immune cells in allergic airway inflammation.
    Allergy. 2023 May 12. doi: 10.1111/all.15766.
    PubMed    
    
    
    
73. ROVIRA RUBIO J, Megremis S, Pasioti M, Lakoumentas J, et al
    Respiratory virome profiles reflect antiviral immune responses.
    Allergy. 2023;78:1258-1268.
    PubMed     Abstract available
    
    
    
74. LICCARDI G, Bilo MB, Calzetta L, Milanese M, et al
    Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study.
    Allergy. 2023;78:1360-1363.
    PubMed    
    
    
    April 2023
75. JUTEL M, Mosnaim GS, Bernstein JA, Del Giacco S, et al
    The One Health approach for allergic diseases and asthma.
    Allergy. 2023 Apr 29. doi: 10.1111/all.15755.
    PubMed     Abstract available
    
    
    
76. DENTON E, O'Hehir RE, Hew M
    The changing global prevalence of asthma and atopic dermatitis.
    Allergy. 2023 Apr 27. doi: 10.1111/all.15754.
    PubMed    
    
    
    
77. RABE KF, Pavord ID, Busse WW, Chupp GL, et al
    Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status.
    Allergy. 2023 Apr 19. doi: 10.1111/all.15747.
    PubMed     Abstract available
    
    
    
78. PAPADOPOULOS NG, Szefler SJ, Bacharier LB, Maspero JF, et al
    Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
    Allergy. 2023 Apr 14. doi: 10.1111/all.15743.
    PubMed     Abstract available
    
    
    
79. BOUSQUET J, Shamji MH, Anto JM, Schunemann HJ, et al
    Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach.
    Allergy. 2023 Apr 11. doi: 10.1111/all.15740.
    PubMed     Abstract available
    
    
    
80. YAO L, Yuan X, Fu H, Guo Q, et al
    Epithelium-derived cystatin SN inhibits HDM protease activity in allergic asthma.
    Allergy. 2023 Apr 7. doi: 10.1111/all.15739.
    PubMed     Abstract available
    
    
    March 2023
81. BJORKANDER S, Maier P, Kere M, Merid SK, et al
    Innate lymphoid cells type 2 and CD8(+) T cells are perturbed in overweight and obese individuals with asthma.
    Allergy. 2023 Mar 30. doi: 10.1111/all.15728.
    PubMed    
    
    
    
82. ANNESI-MAESANO I, Cecchi L, Benedetta B, Chung KF, et al
    Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
    Allergy. 2023 Mar 24. doi: 10.1111/all.15724.
    PubMed     Abstract available
    
    
    
83. SETHI GS, Gracias DT, Gupta RK, Carr D, et al
    Anti-CD3 Inhibits Circulatory and Tissue-resident Memory CD4 T Cells that Drive Asthma Exacerbations in Mice.
    Allergy. 2023 Mar 23. doi: 10.1111/all.15722.
    PubMed     Abstract available
    
    
    
84. LIN T, Jonathan P, Denton E, Lee J, et al
    Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment.
    Allergy. 2023 Mar 20. doi: 10.1111/all.15719.
    PubMed     Abstract available
    
    
    
85. YORGANCIOGLU A, Reddel HK
    Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care.
    Allergy. 2023 Mar 18. doi: 10.1111/all.15714.
    PubMed    
    
    
    
86. PFEFFER PE, Ali N, Murray R, Ulrik C, et al
    Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.
    Allergy. 2023 Mar 17. doi: 10.1111/all.15711.
    PubMed     Abstract available
    
    
    
87. MOVASSAGH H, Prunicki M, Kaushik A, Zhou X, et al
    Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma.
    Allergy. 2023 Mar 16. doi: 10.1111/all.15692.
    PubMed     Abstract available
    
    
    
88. JANSON C, Melen E, Licht SF, Telg G, et al
    Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden.
    Allergy. 2023 Mar 15. doi: 10.1111/all.15710.
    PubMed    
    
    
    
89. LOMMATZSCH M, Dost M, Jaishankar N, Weise M, et al
    Dupilumab treatment increases transitional B cells in severe asthma.
    Allergy. 2023 Mar 8. doi: 10.1111/all.15703.
    PubMed    
    
    
    
90. PEREZ DE LLANO L, Marina Malanda N, Urrutia I, Martinez-Moragon E, et al
    Factors associated with suboptimal response to monoclonal antibodies in severe asthma.
    Allergy. 2023 Mar 3. doi: 10.1111/all.15693.
    PubMed    
    
    
    
91. ROBB CT, Zhou Y, Felton JM, Zhang B, et al
    Metabolic regulation by prostaglandin E(2) impairs lung group 2 innate lymphoid cell responses.
    Allergy. 2023;78:714-730.
    PubMed     Abstract available
    
    
    
92. ORSI L, Savoure M, Bousquet J, Jacquemin B, et al
    Indoor visible moulds and rhinitis in adults: The EGEA study.
    Allergy. 2023;78:864-867.
    PubMed    
    
    
    February 2023
93. HSU YT, Wu CC, Wang CC, Chung WY, et al
    BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters.
    Allergy. 2023 Feb 28. doi: 10.1111/all.15683.
    PubMed    
    
    
    
94. GU BH, Choi JP, Park T, Kim AS, et al
    Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome.
    Allergy. 2023 Feb 27. doi: 10.1111/all.15691.
    PubMed     Abstract available
    
    
    
95. DOYEN V, Poirot A, Maumy-Bertrand M, Bertrand F, et al
    Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma.
    Allergy. 2023 Feb 22. doi: 10.1111/all.15681.
    PubMed    
    
    
    
96. LAMANNA E, Conde E, Mougel A, Bonnefoy J, et al
    A vaccine targeting human IL-4 and IL-13 protects against asthma in humanized mice.
    Allergy. 2023 Feb 17. doi: 10.1111/all.15680.
    PubMed    
    
    
    
97. BOUSQUET J, Melen E, Haahtela T, Koppelman GH, et al
    Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis.
    Allergy. 2023 Feb 17. doi: 10.1111/all.15679.
    PubMed     Abstract available
    
    
    
98. WIESE AV, Duhn J, Korkmaz RU, Quell KM, et al
    C5aR1 activation in mice controls inflammatory eosinophil recruitment and functions in allergic asthma.
    Allergy. 2023 Feb 9. doi: 10.1111/all.15670.
    PubMed     Abstract available
    
    
    
99. KIM YH, Lim JO, Kim JS, Kim BY, et al
    Protease allergen-induced HMGB1 contributes to NLRC4 inflammasome-mediated inflammation in experimental asthma.
    Allergy. 2023 Feb 7. doi: 10.1111/all.15668.
    PubMed    
    
    
    
100. SHAMJI MH, Ollert M, Adcock IM, Bennett O, et al
     EAACI Guidelines on environmental science in allergic diseases and asthma - leveraging artificial intelligence and machine learning to develop a causality model in exposomics.
     Allergy. 2023 Feb 5. doi: 10.1111/all.15667.
     PubMed     Abstract available
     
     
     
101. STIKKER BS, Hendriks RW, Stadhouders R
     Decoding the genetic and epigenetic basis of asthma.
     Allergy. 2023 Feb 2. doi: 10.1111/all.15666.
     PubMed     Abstract available
     
     
     
102. MITAMURA Y, Akdis CA
     Single-cell analysis of allergic diseases.
     Allergy. 2023;78:346-348.
     PubMed    
     
     
     January 2023
103. ANDERSON J, Do LAH, Wurzel D, Licciardi PV, et al
     Understanding the increased susceptibility to asthma development in preterm infants.
     Allergy. 2023 Jan 31. doi: 10.1111/all.15662.
     PubMed     Abstract available
     
     
     
104. THURMANN L, Klos M, Mackowiak SD, Bieg M, et al
     Global hypomethylation in childhood asthma identified by genome-wide DNA-methylation sequencing preferentially affects enhancer regions.
     Allergy. 2023 Jan 27. doi: 10.1111/all.15658.
     PubMed     Abstract available
     
     
     
105. SCHULZE J, Agache I, Eguiluz-Gracia I, Trischler J, et al
     Medical algorithm: Diagnosis and treatment of house dust mite-driven allergic asthma.
     Allergy. 2023 Jan 23. doi: 10.1111/all.15654.
     PubMed    
     
     
     
106. POUESSEL G, Alonzo S, Divaret-Chauveau A, Dumond P, et al
     Fatal and near-fatal anaphylaxis: the Allergy-Vigilance(R) Network data (2002-2020).
     Allergy. 2023 Jan 16. doi: 10.1111/all.15645.
     PubMed     Abstract available
     
     
     
107. LEE H, Ryu J, Chung SJ, Park DW, et al
     Overall and respiratory mortality reduction with physical activity in subjects with and without asthma.
     Allergy. 2023 Jan 5. doi: 10.1111/all.15638.
     PubMed    
     
     
     
108. LEE PH, Choi S, An M, Hwang D, et al
     Angiomotin and angiostatin as asthma biomarkers: implications for the regulation of airway remodeling and inflammation.
     Allergy. 2023 Jan 5. doi: 10.1111/all.15637.
     PubMed    
     
     
     December 2022
109. BAJBOUJ K, AbuJabal R, Sahnoon L, Olivenstein R, et al
     IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma.
     Allergy. 2022 Dec 27. doi: 10.1111/all.15627.
     PubMed    
     
     
     
110. GAUVREAU GM, Bergeron C, Boulet LP, Cockcroft DW, et al
     Sounding the Alarmins - The Role of Alarmin Cytokines in Asthma.
     Allergy. 2022 Dec 4. doi: 10.1111/all.15609.
     PubMed     Abstract available
     
     
     
111. ALHAMWE BA, Gao Z, Alhamdan F, Harb H, et al
     Intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with caecal microbiota changes.
     Allergy. 2022 Dec 2. doi: 10.1111/all.15606.
     PubMed     Abstract available
     
     
     
112. NDIKA J, Suojalehto H, Lindstrom I, Airaksinen L, et al
     Systemic gene signature of inhaled corticosteroid treatment in allergic asthma to flour.
     Allergy. 2022 Dec 1. doi: 10.1111/all.15605.
     PubMed    
     
     
     
113. FORDE B, Yao L, Shaha R, Murphy S, et al
     Immunomodulation by foods and microbes: Unravelling the molecular tango.
     Allergy. 2022;77:3513-3526.
     PubMed     Abstract available
     
     
     
114. GISLER A, Eeftens M, de Hoogh K, Vienneau D, et al
     Pollen exposure is associated with risk of respiratory symptoms during the first year of life.
     Allergy. 2022;77:3606-3616.
     PubMed     Abstract available
     
     
     November 2022
115. ALVARADO-VAZQUEZ PA, Cardenas EI, Das A, Hallgren J, et al
     Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma.
     Allergy. 2022 Nov 27. doi: 10.1111/all.15596.
     PubMed    
     
     
     
116. ROSENQUIST NA, Richards M, Ferber JR, Li DK, et al
     Prepregnancy Body Mass Index and Risk of Childhood Asthma.
     Allergy. 2022 Nov 27. doi: 10.1111/all.15598.
     PubMed     Abstract available
     
     
     
117. MUSIOL S, Harris CP, Karlina R, Gostner JM, et al
     Dietary digestible carbohydrates are associated with higher prevalence of asthma in humans and with aggravated lung allergic inflammation in mice.
     Allergy. 2022 Nov 24. doi: 10.1111/all.15589.
     PubMed     Abstract available
     
     
     
118. SUN W, Song S, Li G, Zhou L, et al
     FcRn-targeting and ROS-responsive Fedratinib-incorporated Nanoparticles Alleviate Asthma by Inducing Eosinophil Apoptosis.
     Allergy. 2022 Nov 3. doi: 10.1111/all.15575.
     PubMed    
     
     
     October 2022
119. TAN DJ, Lodge CJ, Walters EH, Lowe AJ, et al
     Biomarkers of asthma relapse and lung function decline in adults with spontaneous asthma remission: a population-based cohort study.
     Allergy. 2022 Oct 27. doi: 10.1111/all.15566.
     PubMed     Abstract available
     
     
     
120. AKENROYE A, Zhou G, Jackson JW, Segal J, et al
     Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study.
     Allergy. 2022 Oct 26. doi: 10.1111/all.15564.
     PubMed    
     
     
     
121. BRADSHAW LE, Wyatt LA, Brown SJ, Haines RH, et al
     Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial.
     Allergy. 2022 Oct 19. doi: 10.1111/all.15555.
     PubMed     Abstract available
     
     
     
122. GURDENIZ G, Kim M, Brustad N, Ernst M, et al
     Furan fatty acid metabolite in newborns predicts risk of asthma.
     Allergy. 2022 Oct 17. doi: 10.1111/all.15554.
     PubMed     Abstract available
     
     
     
123. WALSEMANN T, Bottger M, Traidl S, Schwager C, et al
     Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases.
     Allergy. 2022 Oct 14. doi: 10.1111/all.15553.
     PubMed     Abstract available
     
     
     
124. GAO YD, Xepapadaki P, Cui YW, Stanic B, et al
     Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response, and asthma control in preschool children with asthma.
     Allergy. 2022 Oct 13. doi: 10.1111/all.15551.
     PubMed     Abstract available
     
     
     
125. RADZIKOWSKA U, Golebski K
     Sex hormones and asthma: the role of estrogen in asthma development and severity.
     Allergy. 2022 Oct 10. doi: 10.1111/all.15548.
     PubMed    
     
     
     
126. VIJEYAKUMARAN M, Al Jawhri M, Fortunato J, Solomon L, et al
     Dual Activation of Estrogen Receptor Alpha and Glucocorticoid Receptor Upregulate CRTh2-Mediated Type 2 Inflammation; Mechanism Driving Asthma Severity in Women?
     Allergy. 2022 Oct 7. doi: 10.1111/all.15543.
     PubMed     Abstract available
     
     
     September 2022
127. VAZQUEZ-ORTIZ M, Gore C, Alviani C, Angier E, et al
     A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies - an EAACI Position paper.
     Allergy. 2022 Sep 29. doi: 10.1111/all.15533.
     PubMed     Abstract available
     
     
     
128. ZAITSU M, Kono K, Hosokawa Y, Miyamoto M, et al
     Maternal heated tobacco product use during pregnancy and allergy in offspring.
     Allergy. 2022 Sep 29. doi: 10.1111/all.15536.
     PubMed     Abstract available
     
     
     
129. LEE-SARWAR KA, Chen YC, Chen YY, Kozyrskyj AL, et al
     The Maternal Prenatal and Offspring Early-Life Gut Microbiome of Childhood Asthma Phenotypes.
     Allergy. 2022 Sep 15. doi: 10.1111/all.15516.
     PubMed     Abstract available
     
     
     
130. LIANG Q, Fu J, Wang X, Liu L, et al
     circS100A11 enhances M2a macrophage activation and lung inflammation in children with asthma.
     Allergy. 2022 Sep 14. doi: 10.1111/all.15515.
     PubMed     Abstract available
     
     
     
131. RAVANETTI L, Dekker T, Guo L, Dijkhuis A, et al
     Efficacy of FP-025, a novel Matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma.
     Allergy. 2022 Sep 12. doi: 10.1111/all.15513.
     PubMed    
     
     
     
132. VOGELBERG C, Klimek L, Bruggenjurgen B, Jutel M, et al
     Real-world evidence for the long-term effect of allergen immunotherapy: current status on database-derived European studies.
     Allergy. 2022 Sep 8. doi: 10.1111/all.15506.
     PubMed     Abstract available
     
     
     
133. BOURDIN A, Bommart S, Marin G, Vachier I, et al
     Obesity in women with asthma: baseline disadvantage plus greater small-airway responsiveness.
     Allergy. 2022 Sep 7. doi: 10.1111/all.15509.
     PubMed     Abstract available
     
     
     
134. KILANOWSKI A, Thiering E, Wang G, Kumar A, et al
     Allergic disease trajectories up to adolescence: Characteristics, early-life and genetic determinants.
     Allergy. 2022 Sep 7. doi: 10.1111/all.15511.
     PubMed     Abstract available
     
     
     
135. KOSKINEN A, Lemmetyinen R, Luukkainen A, Kankaanranta H, et al
     Season of birth affects the risk of adult-onset asthma in Finland.
     Allergy. 2022 Sep 6. doi: 10.1111/all.15504.
     PubMed    
     
     
     
136. ONG HH, Andiappan AK, Duan K, Lum J, et al
     Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro.
     Allergy. 2022;77:2778-2793.
     PubMed     Abstract available
     
     
     August 2022
137. MURPHY RC, Chow YH, Lai Y, Al-Shaikhly T, et al
     Identification of Mast Cell Progenitor Cells in the Airways of Individuals with Allergic Asthma.
     Allergy. 2022 Aug 29. doi: 10.1111/all.15498.
     PubMed    
     
     
     
138. CHAOIMH CN, Lad D, Nico C, Puppels GJ, et al
     Early initiation of short-term emollient use for the prevention of atopic dermatitis in high risk infants - the STOP AD randomised controlled trial.
     Allergy. 2022 Aug 23. doi: 10.1111/all.15491.
     PubMed     Abstract available
     
     
     
139. BADI YE, Salcman B, Taylor A, Rana B, et al
     IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma.
     Allergy. 2022 Aug 20. doi: 10.1111/all.15487.
     PubMed     Abstract available
     
     
     
140. VAZQUEZ-MERA S, Martelo-Vidal L, Miguens-Suarez P, Saavedra-Nieves P, et al
     Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity.
     Allergy. 2022 Aug 16. doi: 10.1111/all.15480.
     PubMed     Abstract available
     
     
     
141. VARRICCHI G, Ferri S, Pepys J, Poto R, et al
     Biologics and Airway Remodeling in Severe Asthma.
     Allergy. 2022 Aug 11. doi: 10.1111/all.15473.
     PubMed     Abstract available
     
     
     
142. CARUSO C, Colantuono S, Ciasca G, Basile U, et al
     Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
     Allergy. 2022 Aug 3. doi: 10.1111/all.15466.
     PubMed     Abstract available
     
     
     
143. MUMBY S, Kermani NZ, Garnett JP, Pavlidis S, et al
     CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
     Allergy. 2022 Aug 2. doi: 10.1111/all.15465.
     PubMed    
     
     
     
144. KARLINA R, Flexeder C, Musiol S, Bhattacharyya M, et al
     Differential effects of lung inflammation on insulin resistance in humans and mice.
     Allergy. 2022;77:2482-2497.
     PubMed     Abstract available
     
     
     July 2022
145. PAPI A, Corren J, Castro M, Domingo C, et al
     Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
     Allergy. 2022 Jul 28. doi: 10.1111/all.15456.
     PubMed     Abstract available
     
     
     
146. JEONG JS, Choi JY, Kim JS, Park SO, et al
     SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation.
     Allergy. 2022 Jul 24. doi: 10.1111/all.15452.
     PubMed    
     
     
     
147. HE A, Chen J, Guan J, Huang Y, et al
     Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma.
     Allergy. 2022 Jul 20. doi: 10.1111/all.15448.
     PubMed    
     
     
     
148. MAGGI E, Parronchi P, Azzarone BG, Moretta L, et al
     A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders.
     Allergy. 2022 Jul 16. doi: 10.1111/all.15445.
     PubMed     Abstract available
     
     
     
149. BENAMAR M, Harb H, Chen Q, Wang M, et al
     A Common IL-4 Receptor Variant Promotes Asthma Severity via a Treg Cell GRB2-IL-6-Notch4 Circuit.
     Allergy. 2022 Jul 16. doi: 10.1111/all.15444.
     PubMed     Abstract available
     
     
     
150. DEVRIES A, McCauley K, Fadrosh D, Fujimura KE, et al
     Maternal Prenatal Immunity, Neonatal Trained Immunity, and Early Airway Microbiota Shape Childhood Asthma Development.
     Allergy. 2022 Jul 16. doi: 10.1111/all.15442.
     PubMed     Abstract available
     
     
     
151. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
     The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma.
     Allergy. 2022 Jul 15. doi: 10.1111/all.15438.
     PubMed    
     
     
     
152. NAVARATNA S, Burgess J, Waidyatillake N, Peters RL, et al
     Reply to the correspondence: Bacillus Calmette-Guerin vaccination to prevent childhood asthma-A revised analysis.
     Allergy. 2022;77:2264-2265.
     PubMed    
     
     
     
153. PITTET LF, Curtis N
     Bacillus Calmette-Guerin vaccination to prevent childhood asthma: A revised meta-analysis.
     Allergy. 2022;77:2262-2263.
     PubMed    
     
     
     
154. DIVER S, Haldar K, McDowell PJ, Busby J, et al
     Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
     Allergy. 2022 Jul 1. doi: 10.1111/all.15425.
     PubMed     Abstract available
     
     
     
155. LEE SE, Hopkins C, Mullol J, Msihid J, et al
     Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
     Allergy. 2022;77:2211-2221.
     PubMed     Abstract available
     
     
     June 2022
156. RADZIKOWSKA U, Baerenfaller K, Cornejo-Garcia JA, Karaaslan C, et al
     Omics technologies in allergy and asthma research: an EAACI position paper.
     Allergy. 2022 Jun 17. doi: 10.1111/all.15412.
     PubMed     Abstract available
     
     
     
157. CAIT A, Wedel A, Arntz JL, Duinkerken J, et al
     Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis.
     Allergy. 2022 Jun 11. doi: 10.1111/all.15404.
     PubMed     Abstract available
     
     
     
158. OWORA AH, Li R, Tepper RS, Ramsey CD, et al
     Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort.
     Allergy. 2022 Jun 10. doi: 10.1111/all.15403.
     PubMed    
     
     
     
159. STARK JM, Liu J, Tibbitt CA, Christian M, et al
     A recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH 2 and TH 17 cell responses.
     Allergy. 2022 Jun 3. doi: 10.1111/all.15399.
     PubMed     Abstract available
     
     
     May 2022
160. OOKA T, Raita Y, Fujiogi M, Freishtat RJ, et al
     Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.
     Allergy. 2022 May 27. doi: 10.1111/all.15390.
     PubMed     Abstract available
     
     
     
161. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
     Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
     Allergy. 2022 May 24. doi: 10.1111/all.15386.
     PubMed    
     
     
     
162. CARRARO S, di Palmo E, Licari A, Barni S, et al
     Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
     Allergy. 2022 May 23. doi: 10.1111/all.15385.
     PubMed    
     
     
     
163. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
     RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
     Allergy. 2022 May 20. doi: 10.1111/all.15382.
     PubMed    
     
     
     
164. LOMMATZSCH M, Suhling H, Korn S, Bergmann KC, et al
     Safety of combining biologics in severe asthma: asthma-related and unrelated combinations.
     Allergy. 2022 May 18. doi: 10.1111/all.15379.
     PubMed    
     
     
     
165. SOZENER ZC, Cevhertas L, Satitsuksanoa P, van de Veen W, et al
     Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity.
     Allergy. 2022 May 18. doi: 10.1111/all.15378.
     PubMed    
     
     
     
166. KHALFAOUI L, Symon FA, Couillard S, Hargadon B, et al
     Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma.
     Allergy. 2022 May 17. doi: 10.1111/all.15376.
     PubMed     Abstract available
     
     
     
167. ACKLAND J, Barber C, Heinson A, Azim A, et al
     NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.
     Allergy. 2022 May 16. doi: 10.1111/all.15375.
     PubMed     Abstract available
     
     
     
168. XING Y, Wang MH, Leung TF, Wong CK, et al
     Poultry exposure and environmental protection against asthma in rural children.
     Allergy. 2022 May 9. doi: 10.1111/all.15365.
     PubMed     Abstract available
     
     
     April 2022
169. POTAPOVA E, Bordas-Le Floch V, Schlederer T, Vrtala S, et al
     Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
     Allergy. 2022 Apr 26. doi: 10.1111/all.15327.
     PubMed     Abstract available
     
     
     
170. FARRAIA M, Paciencia I, Mendes FC, Cavaleiro Rufo J, et al
     Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
     Allergy. 2022 Apr 22. doi: 10.1111/all.15321.
     PubMed     Abstract available
     
     
     
171. VAN DER BURG N, Stenberg H, Bjermer L, Diamant Z, et al
     Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
     Allergy. 2022 Apr 22. doi: 10.1111/all.15319.
     PubMed    
     
     
     
172. HARB H, Chatila TA
     Recent Patents in Allergy/Immunology: Method for treating asthma or allergic disease via anti-Notch4 mAb.
     Allergy. 2022 Apr 19. doi: 10.1111/all.15317.
     PubMed    
     
     
     
173. RASMUSSEN SM, Halvard Hansen ES, Stensrud T, Radon K, et al
     Asthma endotypes in elite athletes: A cross-sectional study of European athletes participating in the Olympic Games.
     Allergy. 2022 Apr 15. doi: 10.1111/all.15313.
     PubMed    
     
     
     
174. WENG N, Miller M, Pham AK, Komor AC, et al
     Single-base editing of rs12603332 on chromosome 17q21 with a cytosine base editor regulates ORMDL3 and ATF6alpha expression.
     Allergy. 2022;77:1139-1149.
     PubMed     Abstract available
     
     
     
175. MULLOL J, Laidlaw TM, Bachert C, Mannent LP, et al
     Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
     Allergy. 2022;77:1231-1244.
     PubMed     Abstract available
     
     
     March 2022
176. FARRAIA M, Paciencia I, Castro Mendes F, Cavaleiro Rufo J, et al
     Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.
     Allergy. 2022 Mar 28. doi: 10.1111/all.15295.
     PubMed     Abstract available
     
     
     
177. LI Z, Feng Y, Liu H, Yang H, et al
     Single-cell transcriptomics of mouse lung reveal inflammatory memory neutrophils in allergic asthma.
     Allergy. 2022 Mar 21. doi: 10.1111/all.15286.
     PubMed    
     
     
     
178. PAT Y, Ruckert B, Ogulur I, Yazici D, et al
     Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.
     Allergy. 2022 Mar 10. doi: 10.1111/all.15279.
     PubMed    
     
     
     
179. RYAN D, Flokstra-de Blok BM, Clark E, Gaudin C, et al
     Allergic and hypersensitivity conditions in non-specialist care: Flow-diagrams to support clinical practice.
     Allergy. 2022 Mar 10. doi: 10.1111/all.15273.
     PubMed     Abstract available
     
     
     
180. ZUBERBIER T, Abdul Latiff AH, Abuzakouk M, Aquilina S, et al
     The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
     Allergy. 2022;77:734-766.
     PubMed     Abstract available
     
     
     
181. PAVORD ID, Bel EH, Bourdin A, Chan R, et al
     From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
     Allergy. 2022;77:778-797.
     PubMed     Abstract available
     
     
     February 2022
182. HAAHTELA T, Jantunen J, Saarinen K, Tommila E, et al
     Managing the allergy & asthma epidemic in 2020s - lessons from the Finnish experience.
     Allergy. 2022 Feb 24. doi: 10.1111/all.15266.
     PubMed     Abstract available
     
     
     
183. SOKOLOWSKA M, Rovati GE, Diamant Z, Untersmayr E, et al
     Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19.
     Allergy. 2022 Feb 16. doi: 10.1111/all.15258.
     PubMed     Abstract available
     
     
     
184. JUTEL M, Torres MJ, Palomares O, Akdis CA, et al
     COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
     Allergy. 2022 Feb 11. doi: 10.1111/all.15252.
     PubMed    
     
     
     
185. SOUSA-PINTO B, Fonseca JA, Gemicioglu B, Regateiro FS, et al
     Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma.
     Allergy. 2022 Feb 8. doi: 10.1111/all.15248.
     PubMed    
     
     
     
186. TANG X, Ronnberg E, Safholm J, Thulasingam M, et al
     Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction.
     Allergy. 2022 Feb 4. doi: 10.1111/all.15245.
     PubMed     Abstract available
     
     
     
187. CERPS S, Sverrild A, Ramu S, Nieto-Fontarigo JJ, et al
     House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma.
     Allergy. 2022 Feb 3. doi: 10.1111/all.15243.
     PubMed     Abstract available
     
     
     
188. FIETEN KB, Drijver-Messelink MT, Cogo A, Charpin D, et al
     Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper.
     Allergy. 2022 Feb 3. doi: 10.1111/all.15242.
     PubMed     Abstract available
     
     
     
189. HAYA LK, Mehri R, Somers-Neal S, Van de Mosselaer S, et al
     Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC).
     Allergy. 2022;77:685-687.
     PubMed    
     
     
     January 2022
190. PARR CL, Nystad W, Karlstad O, Oymar K, et al
     Ten year trends of national healthcare costs of asthma, allergic rhinitis and atopic eczema in 3 million Norwegians.
     Allergy. 2022 Jan 20. doi: 10.1111/all.15225.
     PubMed    
     
     
     
191. THEOFANI E, Semitekolou M, Samitas K, Mais A, et al
     TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
     Allergy. 2022 Jan 17. doi: 10.1111/all.15221.
     PubMed     Abstract available
     
     
     
192. NANISHI M, Fujiogi M, Freishtat RJ, Hoptay CE, et al
     Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.
     Allergy. 2022 Jan 9. doi: 10.1111/all.15216.
     PubMed     Abstract available
     
     
     
193. HUANG Y, Li X, Zhu L, Huang C, et al
     Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
     Allergy. 2022 Jan 7. doi: 10.1111/all.15210.
     PubMed     Abstract available
     
     
     
194. AGACHE I, Antolin-Amerigo D, de Blay F, Boccabella C, et al
     EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities.
     Allergy. 2022 Jan 2. doi: 10.1111/all.15203.
     PubMed     Abstract available
     
     
     December 2021
195. SOUSA-PINTO B, Filipe Azevedo L, Jutel M, Agache I, et al
     Development and validation of combined symptom-medication scores for allergic rhinitis.
     Allergy. 2021 Dec 21. doi: 10.1111/all.15199.
     PubMed     Abstract available
     
     
     
196. CORREN J, Pham TH, Gil EG, Salapa K, et al
     Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
     Allergy. 2021 Dec 16. doi: 10.1111/all.15197.
     PubMed     Abstract available
     
     
     
197. JANSEN K, Satitsuksanoa P, Wirz OF, Schneider SR, et al
     T regulatory cells from atopic asthmatic individuals show a Th2-like phenotype.
     Allergy. 2021 Dec 4. doi: 10.1111/all.15193.
     PubMed    
     
     
     November 2021
198. DELGADO-DOLSET MI, Obeso D, Rodriguez-Coira J, Tarin C, et al
     Understanding uncontrolled severe allergic asthma by integration of omic and clinical data.
     Allergy. 2021 Nov 28. doi: 10.1111/all.15192.
     PubMed     Abstract available
     
     
     
199. MISHRA A, Majid D, Kandikattu HK, Yadavalli CS, et al
     Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.
     Allergy. 2021 Nov 20. doi: 10.1111/all.15180.
     PubMed     Abstract available
     
     
     October 2021
200. LUNDING LP, Skouras DB, Vock C, Dinarello CA, et al
     The NLRP3 Inflammasome Inhibitor, OLT1177((R)) , Ameliorates Experimental Allergic Asthma in Mice.
     Allergy. 2021 Oct 30. doi: 10.1111/all.15164.
     PubMed    
     
     
     
201. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
     Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
     Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
     PubMed     Abstract available
     
     
     
202. SOUSA-PINTO B, Anto JM, Sheikh A, de Lusignan S, et al
     Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England.
     Allergy. 2021 Oct 19. doi: 10.1111/all.15139.
     PubMed    
     
     
     
203. ADJIBADE M, Davisse-Paturet C, Bernard JY, Adel-Patient K, et al
     Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort.
     Allergy. 2021 Oct 9. doi: 10.1111/all.15137.
     PubMed     Abstract available
     
     
     
204. PAPI A, Jesenak M, Alfano F, Peroni DG, et al
     The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
     Allergy. 2021 Oct 6. doi: 10.1111/all.15131.
     PubMed     Abstract available
     
     
     
205. GERTH VAN WIJK R, Dahl R
     Pros and cons: Should AIT be considered in all patients with allergic asthma?
     Allergy. 2021 Oct 4. doi: 10.1111/all.15123.
     PubMed     Abstract available
     
     
     
206. SMITH AM, Ramirez RM, Harper N, Jimenez F, et al
     Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma.
     Allergy. 2021 Oct 4. doi: 10.1111/all.15124.
     PubMed     Abstract available
     
     
     
207. KIM JM, Im YN, Chung YJ, Youm JH, et al
     Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
     Allergy. 2021 Oct 3. doi: 10.1111/all.15121.
     PubMed     Abstract available
     
     
     September 2021
208. KIM YC, Choi S, Sohn KH, Bang JY, et al
     Selenomonas: a marker of asthma severity with the potential therapeutic effect.
     Allergy. 2021 Sep 29. doi: 10.1111/all.15114.
     PubMed    
     
     
     
209. RAIFER H, Schulz AR, Theodorou J, Romero-Olmedo AJ, et al
     Mass cytometry-based identification of a unique T-cell signature in childhood allergic asthma.
     Allergy. 2021 Sep 26. doi: 10.1111/all.15110.
     PubMed    
     
     
     
210. KHALEVA E, Knibb R, DunnGalvin A, Vazquez-Ortiz M, et al
     Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.
     Allergy. 2021 Sep 26. doi: 10.1111/all.15109.
     PubMed     Abstract available
     
     
     August 2021
211. JANTUNEN J, Kauppi P, Linna M, Makela M, et al
     Real-world evidence of reduced disability costs during the Finnish Allergy Programme 2008-2018.
     Allergy. 2021 Aug 30. doi: 10.1111/all.15070.
     PubMed    
     
     
     
212. SCHRODER A, Lunding LP, Zissler UM, Vock C, et al
     IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33.
     Allergy. 2021 Aug 30. doi: 10.1111/all.15072.
     PubMed     Abstract available
     
     
     
213. ZHAN C, Liu J, Li B, Xu R, et al
     Group 2 Innate Lymphoid Cells in Patients with Non-Asthmatic Eosinophilic Bronchitis.
     Allergy. 2021 Aug 29. doi: 10.1111/all.15068.
     PubMed    
     
     
     
214. TRAMPER-STRANDERS G, Ambrozej D, Arcolaci A, Atanaskovic-Markovic M, et al
     Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases.
     Allergy. 2021 Aug 13. doi: 10.1111/all.15046.
     PubMed     Abstract available
     
     
     June 2021
215. GIANG N, Mars M, Moreau M, Mejia JE, et al
     Separation of the CaV 1.2-CaV 1.3 calcium channel duo prevents type-2 allergic airway inflammation.
     Allergy. 2021 Jun 28. doi: 10.1111/all.14993.
     PubMed     Abstract available
     
     
     
216. SIROUX V, Boudier A, Bousquet J, Dumas O, et al
     Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort.
     Allergy. 2021 Jun 25. doi: 10.1111/all.14987.
     PubMed     Abstract available
     
     
     
217. LOSOL P, Kim SH, Ahn S, Lee S, et al
     Genetic variants in the TLR-related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients.
     Allergy. 2021 Jun 1. doi: 10.1111/all.14970.
     PubMed    
     
     
     May 2021
218. PFAAR O, Bergmann KC, Bonini S, Compalati E, et al
     Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
     Allergy. 2021 May 24. doi: 10.1111/all.14957.
     PubMed     Abstract available
     
     
     
219. VENTER C, Palumbo MP, Glueck DH, Sauder KA, et al
     The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study.
     Allergy. 2021 May 21. doi: 10.1111/all.14949.
     PubMed     Abstract available
     
     
     
220. THURMANN L, Herberth G, Seiwert B, Schlittenbauer L, et al
     Prenatal paraben exposure and atopic dermatitis-related outcomes among children.
     Allergy. 2021 May 2. doi: 10.1111/all.14890.
     PubMed     Abstract available
     
     
     April 2021
221. HEMMER W, Sestak-Greinecker G, Braunsteiner T, Wantke F, et al
     Molecularsensitization patterns in animal allergy: relationship with clinical relevance and pet ownership.
     Allergy. 2021 Apr 29. doi: 10.1111/all.14885.
     PubMed     Abstract available
     
     
     
222. MINDAYE ST, Sun C, Esfahani SAZ, Matsui EC, et al
     Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno-allergomic approach.
     Allergy. 2021 Apr 17. doi: 10.1111/all.14860.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.